In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Molplex Pharmaceuticals

www.molplex.com

Latest From Molplex Pharmaceuticals

Start-Up Previews, February 2015

This Month's Profile Group, BioHub At Alderley Park, features profiles of Absynth Biologics, Blueberry Therapeutics, Molplex Pharmaceuticals, and OncoTherics. Plus these Start-Ups Across Health Care: Centerline Biomedical, Laurimed, and Portal Instruments.

BioPharmaceutical

Molplex Pharmaceuticals

Molplex Pharmaceuticals’ drug discovery platform, Optiplex, uses a combination of artificial intelligence and highly automated decision-making systems in drug optimization, selecting compounds with maximum potential for efficacy combined with minimum side effects. The Optiplex database contains almost a trillion chemical structures, as well as predicted biological activities for more than a thousand human protein targets and ADME-tox properties.

BioPharmaceutical

BioHub At Alderley Park: A Bioincubator With A Difference

Once an R&D site for AstraZeneca, the BioHub at Alderley Park is now home to a number of emerging biotechs. Profiles of Absynth Biologics, Blueberry Therapeutics, Molplex, and OncoTherics.

BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Molplex Pharmaceuticals
  • Senior Management
  • David Leahy, PhD, CEO
  • Contact Info
  • Molplex Pharmaceuticals
    Phone: 1625 238713
    The BioHub at Alderley Park, Mereside
    Alderley Edge
    Cheshire, SK10 4TG
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register